Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy-Reference-Cited by-同舟云学术

Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy

Published:2017-07-26 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Goh Ee Teng¹,Andersen Mette L²,Morgan Marsha Y¹,Gluud Lise Lotte³

Affiliation:

1. Division of Medicine, Royal Free Campus, University College London; UCL Institute for Liver & Digestive Health; Rowland Hill Street Hampstead London UK NW3 2PF

2. Rigshospitalet; Department of Hepatology; Blegdamsvej 9 Dept. 2121 Copenhagen Denmark 2100

3. Copenhagen University Hospital Hvidovre; Gastrounit, Medical Division; Kettegaards Alle Hvidovre Denmark 2650

Publisher

Wiley

Subject

Pharmacology (medical)

Reference111 articles.

1. Effects of flumazenil on subclinical hepatic encephalopathy (SHE): preliminary data;Amodio;Italian Journal of Gastroenterology,1993

2. Effects of flumazenil on subclinical hepatic encephalopathy;Amodio;Journal of Hepatology,1993

3. The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double-blind placebo-controlled study;Amodio;Clinical Physiology,1997

4. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, crossover study;Barbaro;Hepatology (Baltimore, Md.),1998

5. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study;Barbaro;European Journal of Emergency Medicine,1998

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antidotes in Clinical Toxicology—Critical Review;Toxics;2023-08-23